NP40919 Paracetamol 1G Solution for Infusion & Rocuronium Bromide Injection
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 2 year (est.)
- Value
- £827K
- Sector
- HEALTH
- Published
- 05 Dec 2023
- Delivery
- To 29 Jan 2026 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
2 suppliers
- B Braun Medical Sheffield
- Bowmed Ibisqus Wrexham
Description
Supply of Paracetamol 1G Solution for Infusion & Rocuronium Bromide Injection to NHS Scotland
Lot Division
| 1 | Paracetamol 1G Solution For Infusion Lot 1 – the supply of Paracetamol 1G/100ml (10mg/ml) Solution For Infusion to NHS Scotland. The Authority has awarded this Lot as a single supplier framework agreement to one (1) Framework Participant. |
| 2 | Rocuronium Bromide Injection Lot 2 – the supply of Rocuronium Bromide 100mg/10ml (10mg/ml) Injection and Rocuronium Bromide 50mg/5ml (10mg/ml) Injection to NHS Scotland. The Authority has awarded this Lot as a single supplier framework agreement to one (1) Framework Participant. |
Award Detail
| 1 | B Braun Medical (Sheffield)
|
| 2 | Bowmed Ibisqus (Wrexham)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015
Other Information
The estimated value(s) of the Framework Agreement referred to in Section V.2.4 (comprising two (2) Lots) cover(s) the twenty-four(24) month duration of the proposed modification period of the Framework Agreement. (SC Ref:751833)
Reference
- FTS 035853-2023